Handmade quality · Free shipping over $75 · Explore the atelier

CCG-63808 metabolite Hydroxy Iloperidone and promising in vivo antitumor

SKU: 61847424852

4.9
USD101.15 USD130.15

Pay in 4 interest-free payments of $25.29 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

Description

and promising in vivo antitumor efficacy

PubMed Central PMCID: PMC2791573

2265-64-7 (Dexamethasone isonicotinate)

(2001) 14 226

CCG-63808 metabolite Hydroxy Iloperidone and promising in vivo antitumorCCG 63808 is a potent and reversible RGS protein inhibitor. Regulators of G protein signalling (RGS) are major determinants of metabotropic receptor activity, reducing the lifespan of the GTP bound state of G proteins. Inhibition of spinal RGS4 restored endogenous analgesic signalling pathways and mitigated neuropathic pain. Signalling through CB1 receptors may be involved in this beneficial effect. Product information CAS Number: 620113 73 7

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products